ADAM17 and inflammatory bowel disease: The intestinal mucosa of IBD patients demonstrates an up-regulation of MMPs and ADAM17 (TNF-α converting enzyme; TACE), which is commonly correlated with disease severity but is not accompanied by an up-regulation of TIMP (78).